跳至主要内容
临床试验/NCT02289170
NCT02289170Unknown不适用

A Randomized, Double-blind, Multicenter, Parallel Designed Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) in Patients With Chronic Low Back Pain

Eun Jung Kim2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
Eun Jung Kim
入组人数
80
试验地点
2
主要终点
Change from baseline in 100mm Pain Visual Analogue Scale (VAS)

研究概览

简要总结

The purpose of this study is to verify the efficacy and safety of heating and cooling combination therapeutic device (OCH-S100) for patients with chronic low back pain (LBP).

详细描述

The investigators targeted the patients with chronic LBP. After treatment in 2 groups - real heating and cooling combination treatment and sham heating and cooling combination treatment - the investigators will compare the effects of pain relief and improvement in disability and range of motion of lumbar region. So the investigators will confirm the efficacy of heating and cooling combination therapy, and further the best treatment method. In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 20 years of age, but below 75 years of age
  • Low back pain in the last 3 months or more
  • Low back pain rated over 40 mm on a 100 mm Visual Analog Scale (VAS)
  • Those who are reliable and willing to cooperate in this test, and obey the restrictions for the treatment period.
  • An understanding of the objectives, methods and efficacy of the clinical trial, and willingness in completing the consent form.

排除标准

  • Trauma to or surgery on the lumbar region within 6 months prior to enrollment
  • Low back pain accompanied by sciatica
  • Systematic disease, and severe dysfunction due to the medical illness (e.g. cancer, infection, etc.)
  • A history of medication, oriental medical treatment, physiotherapy for treating low back pain within the last 4 weeks
  • Neurological disease, such as topical or whole body hypoesthesia in temperature sensation (e.g. stroke, peripheral neuropathy, etc.)
  • Hypersensitivity in heating and cooling stimulation
  • Pregnant and lactating women
  • Participate in the other clinical trials within the last 3 months or after enroll this trial
  • When researchers evaluate that it is not appropriate to participate in this clinical test

结局指标

主要结局

Change from baseline in 100mm Pain Visual Analogue Scale (VAS)

时间窗: at baseline and 4 4 weeks later from baseline

The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'

次要结局

  • Change from baseline in 100mm Pain Visual Analogue Scale (VAS)(estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment)
  • Change from baseline in Traditional Medicine Back pain Questionnaire (TMBQ)(at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment)
  • Change from baseline in Modified schöber test(at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment)
  • Change from baseline in Korean Oswestry disability index (KODI)(at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment)
  • Change from baseline in Korean Roland Morris Disability Questionnaire (KRMDQ)(at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment)
  • Change from baseline in Finger-to-floor distance(at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment)
  • Change from baseline in Finger-to-thigh distraction(at baseline, 2 weeks and 4 weeks later from baseline, and 4 weeks later from the end of treatment)
  • Adverse Events(estimately every 2.8 days from baseline to 4 weeks later, and 4 weeks later from the end of treatment)

研究者

发起方
Eun Jung Kim
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Eun Jung Kim

Clinical trial Chief of Research

DongGuk University

研究点 (2)

Loading locations...

相似试验

Clinical Study to Evaluate the Safety and Efficacy... | 临床试验